Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.57B |
| 2 |
Microsoft
MSFT
|
+$1.4B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Amazon
AMZN
|
+$1.19B |
| 5 |
Broadcom
AVGO
|
+$1.13B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WRK
WestRock Company
WRK
|
+$316M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$187M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$159M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$139M |
| 5 |
Cadence Design Systems
CDNS
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.03% |
| 2 | Financials | 12.84% |
| 3 | Healthcare | 11.54% |
| 4 | Consumer Discretionary | 10.45% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4101
Worksport
WKSP
$10.5M
| $101K | ﹤0.01% |
23,657
+4,053
| +21% | +$25.3K |
|
|
BSIN
4102
Big Sky Industrial
BSIN
$63.3M
| $101K | ﹤0.01% |
87,772
+19,350
| +28% | +$19.3K |
|
4103
flyExclusive
FLYX
$62.1M
| $101K | ﹤0.01% |
33,879
+9,121
| +37% | +$36.4K |
|
4104
HCW Biologics
HCWB
$5.45M
| $98.9K | ﹤0.01% |
764
+54
| +8% | +$7.36K |
|
|
PMD
4105
DELISTED
Psychemedics Corporation
PMD
| $98.6K | ﹤0.01% |
42,679
+5,474
| +15% | +$12.3K |
|
4106
China Automotive Systems
CAAS
$133M
| $98.3K | ﹤0.01% |
21,380
| – | – |
|
4107
Generation Income Properties
GIPR
$743K
| $97.6K | ﹤0.01% |
4,457
+119
| +3% | +$3.21K |
|
4108
Precipio
PRPO
$42.8M
| $97.6K | ﹤0.01% |
14,458
-700
| -5% | -$4.03K |
|
|
FTH
4109
Faeth Therapeutics
FTH
$629M
| $97.6K | ﹤0.01% |
8,157
| – | – |
|
|
AKTS
4110
DELISTED
Akoustis Technologies Inc
AKTS
| $97.2K | ﹤0.01% |
1,086,182
+88,648
| +9% | +$8.51K |
|
|
GGRP
4111
Glimpse Group
GGRP
$18.7M
| $97K | ﹤0.01% |
128,341
+20,367
| +19% | +$18.2K |
|
4112
BioRestorative Therapies
BRTX
$5.2M
| $96.9K | ﹤0.01% |
55,706
+3,369
| +6% | +$5.55K |
|
|
MTLS
4113
Materialise
MTLS
$396M
| $96K | ﹤0.01% |
17,527
| – | – |
|
4114
Stran & Co
SWAG
$36.5M
| $95.8K | ﹤0.01% |
78,527
-13,801
| -15% | -$16.5K |
|
|
SYBX
4115
DELISTED
Synlogic
SYBX
| $95.7K | ﹤0.01% |
64,234
+4,649
| +8% | +$7.06K |
|
4116
Avalo Therapeutics
AVTX
$983M
| $95.6K | ﹤0.01% |
+10,111
| New | +$104K |
|
4117
Cumberland Pharmaceuticals
CPIX
$117M
| $95.1K | ﹤0.01% |
74,305
-14,441
| -16% | -$20K |
|
4118
Monopar Therapeutics
MNPR
$799M
| $94.8K | ﹤0.01% |
14,066
+2,059
| +17% | +$6.89K |
|
4119
Local Bounti
LOCL
$23.5M
| $94.3K | ﹤0.01% |
37,702
-1,108
| -3% | -$2.94K |
|
4120
LiqTech
LIQT
$21M
| $93.8K | ﹤0.01% |
36,679
+6,457
| +21% | +$16.3K |
|
4121
VerifyMe
VRME
$9.15M
| $93.4K | ﹤0.01% |
65,304
+3,400
| +5% | +$4.29K |
|
4122
Optical Cable Corp
OCC
$143M
| $93.3K | ﹤0.01% |
34,814
-2,044
| -6% | -$5.56K |
|
4123
XWELL
XWEL
$8.66M
| $92.7K | ﹤0.01% |
53,560
+7,173
| +15% | +$13.2K |
|
4124
reAlpha
AIRE
$7.83M
| $92.7K | ﹤0.01% |
2,918
+553
| +23% | +$18.5K |
|
4125
Edesa Biotech
EDSA
$50.8M
| $92.6K | ﹤0.01% |
20,809
+2,590
| +14% | +$11.8K |
|
Similar funds
Geode Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Geode Capital Management held 4,685 positions worth $1.23T, up 8.4% from $1.14T the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Geode Capital Management's Q3 2024 filing shows 98 new, 3,266 increased, 979 reduced and 150 closed positions. Its largest new stake was Smurfit Westrock: 12,733,113 shares worth $627M. The largest sale was WestRock Company, an estimated $316M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2024 buy was Smurfit Westrock: 12,733,113 shares worth $627M.
- Geode Capital Management added most to Apple in Q3 2024, an estimated $4.57B increase.
- Geode Capital Management's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $187M.
- Geode Capital Management fully exited WestRock Company in Q3 2024, selling an estimated $316M.
- Geode Capital Management's ten largest holdings make up 30% of its $1.23T portfolio in Q3 2024.
- Geode Capital Management opened 98 new positions and closed 150 in Q3 2024.
- Geode Capital Management's portfolio value rose 8.4% quarter-over-quarter to $1.23T.
Based on Geode Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.